Skip to main content

Table 3 Top 10 hsa-miR-182-5p-related differentially expressed genes in ovarian cancer tissues compared with normal ovarian tissues according to data from Gene Expression Omnibus (GSE14407)

From: Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis

DEG

logFC

P.Value

adj. P.Value

up-regulated genes

 MECOM

4.902333971

9.81E-08

1.99E-05

 TFAP2A

4.745918435

1.88E-08

6.04E-06

 DEPDC1

4.032946443

5.66E-09

3.03E-06

 AIF1L

3.868411982

3.79E-08

9.54E-06

 BIRC5

3.7736042

8.61E-09

3.89E-06

 BCL11A

3.534029736

1.11E-06

1.13E-04

 L1CAM

3.279255511

1.66E-06

1.49E-04

 HMMR

3.262907245

2.33E-06

1.95E-04

 NCAPG

3.229344903

1.07E-08

4.36E-06

 DTL

3.208682435

1.51E-10

3.76E-07

down-regulated genes

 PDE7B

−5.031930277

6.84E-09

3.37E-06

 TCEAL7

−4.928868798

4.70E-09

2.66E-06

 DCN

−4.886965887

1.16E-08

4.61E-06

 GPM6A

−4.799779935

2.81E-08

7.77E-06

 PGR

−4.345763842

2.85E-08

7.83E-06

 PPM1E

−4.270922539

1.43E-08

5.13E-06

 TMOD2

−4.108261122

5.21E-10

7.49E-07

 NKX3–1

−3.851343755

1.34E-07

2.48E-05

 TACC1

−3.745549626

5.00E-08

1.18E-05

 FGF13

−3.684968538

2.31E-09

1.78E-06

  1. DEG differentially expressed gene, FC fold-change